Levesque, N.; Mitchinson, K.; Lawrie, D.; Fedorak, L.; MacDonald, D.; Normand, C.; Pouliot, J.F. Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma. Curr. Oncol. 2008, 15, 36-41. https://doi.org/10.3747/co.2008.200

AMA Style

Levesque N, Mitchinson K, Lawrie D, Fedorak L, MacDonald D, Normand C, Pouliot JF. Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma. Current Oncology. 2008; 15(1):36-41. https://doi.org/10.3747/co.2008.200

Chicago/Turabian Style

Levesque, N., K. Mitchinson, D. Lawrie, L. Fedorak, D. MacDonald, C. Normand, and J.F. Pouliot. 2008. "Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma" Current Oncology 15, no. 1: 36-41. https://doi.org/10.3747/co.2008.200

APA Style

Levesque, N., Mitchinson, K., Lawrie, D., Fedorak, L., MacDonald, D., Normand, C., & Pouliot, J. F. (2008). Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma. Current Oncology, 15(1), 36-41. https://doi.org/10.3747/co.2008.200

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI